Abstract
Recently, new water- and blood-soluble nitronyl nitroxides, 2-(5-methyl-1H-imidazole-4-yl)-4,4,5,5-tetramethyl-4,5-dihydroimidazole-3-oxide-1-oxyl (NN1) and 2-(1H-imidazole-4-yl)-4,4,5,5-tetramethyl-4,5-dihydroimidazole-3-oxide-1-oxyl (NN2), (Fig. 1), were synthesized and used as contrast agents for MRI (Savelov et al. Dokl Academ Nauk 416(4): 493–495, 2007). Taking into account the high rate constants of NN’s reduction by ascorbic acid and other biologically relevant reductants, it is not clear which factors helped with the use of these nitroxides in vivo as a contrast reagent. Moreover, due to high solubility in an aqueous solution and low toxicity (Ovcharenko et al. in Dokl Academ Nauk 404(2):198–200, 2005, Eriksson et al. in Drug Metab Dispos 15(2):155–160, 1987, Afzal et al. in Polyhedron 22(14):1957–1964, 2003) of NNs, it seems possible to use them as a spin probe for NO in vivo with EPR tomography. In this paper, we studied reduction of NN1 and NN2 in model conditions (by ascorbic acid) and in vitro. In addition, the possibility of NN1 and NN2 to be used as paramagnetic probes for L-band EPR imaging in vivo was investigated. Nitric oxide (NO) expression in vivo leads to the decrease in concentrations of NN1, 2 upon the injection in a mouse body, that can be explained by the reaction of studied radicals with NO and fast transformation of the reaction products to diamagnetic species. Pharmacokinetics of NN1, 2 and limitations of their application as contrast agents in MRI are discussed also. Finally, the results of EPR tomography were compared with MRI data. It is shown that the fast reduction of the reaction product of NN with NO—imino nitroxides—is the main obstacle to use NN as a spin probe in vivo.
Similar content being viewed by others
References
Y. Yoon, J.H. Song, S.H. Hong, J. Q Kim, Clin. Chem. 46(10), 1626–1630 (2000)
R.A. Hopper, J. Garthwaite, J. Neurosci. 26(45), 11513–11521 (2006)
D.E. Koshland, E. Culotta, Science 258(5090), 1862–1865 (1992)
V.I. Yelinova, V.V. Khramtsov, A.L. Markel, Biochem. Biophys. Res. Commun. 263, 450–453 (1999)
E.F. Ullman, L. Call, J.H. Osiecki, J. Org. Chem. 35, 3623–3631 (1970)
T. Akaike, M. Yoshida, Y. Miyamoto, K. Sato, M. Kohno, K. Sasamoto, K. Miyazaki, S. Ueda, H. Maeda, Biochemistry 32, 827–832 (1993)
Y.Y. Woldman, V.V. Khramtsov, I.A. Grigor’ev, I.A. Kiriljuk, D.I. Utepbergenov, Biochem. Biophys. Res. Commun. 202, 195–203 (1994)
Y. Zhang, N. Hogg, Free Radic. Biol. Med. 32, 1212–1219 (2003)
J. Joseph, B. Kalyanaraman, J.S. Hyde, Biochem. Biophys. Res. Commun. 192, 926–934 (1993)
A. Mori, Y. Noda, L. Packer, Epilepsy Res. 30, 153–158 (1998)
G.M. Pieper, W. Siebeneich, J. Pharmacol. Exp. Ther. 283, 138–147 (1997)
M. Yoshida, T. Akaike, Y. Wada, K. Sato, K. Ikeda, S. Ueda, H. Maeda, Biochem. Biophys. Res. Comm. 202, 923–930 (1994)
R.J. Singh, N. Hogg, F. Neese, J. Joseph, B. Kalyanaraman, Photochem. Photobiol. 61, 325–330 (1995)
N. Hogg, R.J. Singh, J. Joseph, F. Neese, B. Kalyanaraman, Free Radic. Res. 22, 47–56 (1995)
R.F. Haseloff, S. Zollner, I.A. Kirilyuk, I.A. Grigor’ev, R. Reszka, R. Bernhardt, K. Mertsch, B. Roloff, I.E. Blasig, Free Radic. Res. 26, 7–17 (1997)
A.A. Bobko, E.G. Bagryanskaya, V.A. Reznikov, N.G. Kolosova, T.L. Clanton, V.V. Khramtsov, Free Radic. Biol. Med. 36(2), 248–258 (2004)
G.M. Rosen, S. Porasuphatana, P. Tsai, N.P. Ambulos, V.E. Galtsev, K. Ichikawa, H.J. Halpern, Macromolecules 36, 1021–1027 (2003)
A.A. Bobko, A. Ivanov, V.V. Khramtsov, Free Radic. Res. 47(2), 74–81 (2013)
V. Khramtsov, L.J. Berliner, T.L. Clanton, Magn. Reson. Med. 42, 228–234 (1999)
V.V. Khramtsov, V.A. Reznikov, L.J. Berliner, A.K. Litkin, I.A. Grigor’ev, T.L. Clanton, Free Radic. Biol. Med. 30, 1099–1107 (2001)
D.I. Potapenko, T.L. Clanton, E.G. Bagryanskaya, N.P. Gritsan, V.A. Reznikov, V.V. Khramtsov, Free Radic. Biol. Med. 34(2), 196–206 (2003)
A.A. Bobko, S.V. Sergeeva, E.G. Bagryanskaya, A.L. Markel, V.V. Khramtsov, V.A. Reznikov, N.G. Kolosova, Biochem. Biophys. Res. Commun. 330(2), 367–370 (2005)
V.I. Ovcharenko, EYu. Fursova, T.G. Tolstikova, K.N. Sorokina, AYu. Letyagin, A.A. Savelov, Dokl. Acad. Nauk. 404(2), 198–200 (2005)
A.A. Savelov, D.A. Kokorin, EYu. Fursova, V.I. Ovcharenko, Dokl. Acad. Nauk. 416(4), 493–495 (2007)
U.G. Eriksson, R.C. Brasch, T.N. Tozer, Drug Metab. Dispos. 15(2), 155–160 (1987)
V. Afzal, R.C. Brasch, D.E. Nitecki, S. Wolff, Investig. Radiol. 19(6), 549–552 (1984)
E. Fursova, G. Romanenko, V. Ikorskii, V. Ovcharenko, Polyhedron 22(14), 1957–1964 (2003)
S. Okazaki, M.A. Mannan, K. Sawai, T. Masumizu, Y. Miura, K. Takeshita, Free Radic. Res. 41(10), 1069–1077 (2007)
J.E. Harkness, J.E. Wagner, The Biology and Medicine of Rabbits and Rodents, 3rd edn. (Lea&Febiger, Philadelphia, 1989)
A.A. Bobko, I.A. Kirilyuk, I.A. Grigor’ev, J.L. Zweier, V.V. Khramtsov, Free Radic. Biol. Med. 42, 404–412 (2007)
E.N. Todhunter, T.J. McMillan, J. Nutr. 31(5), 573–580 (1946)
S.V. Blagodatskikh, V.K. Piotrovskii, V.I. Metelits, O.S. Riabokon’, SIu Martsevich, Farmakol. Toksikol. 50(6), 59–63 (1987)
S.J. Chung, H.L. Fung, Biochem. Pharmacol. 45(1), 157–163 (1993)
E. Coronado, C. Giménez-Saiz, M. Nicolas, F.M. Romero, E. Rusanov, H. Stoeckli-Evans, New J. Chem. 27, 490–497 (2003)
Acknowledgments
This work was supported by the Russian Foundation for Basic Research (project nos. 12-04-014350 and 14-03-32024) and the Russian Science Foundation (project no. 14-14-00922).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Strizhakov, R.K., Shundrin, L.A., Kolosova, N.G. et al. Nitronyl Nitroxides as a Spin Probe in EPR Tomography In Vivo. Appl Magn Reson 45, 743–758 (2014). https://doi.org/10.1007/s00723-014-0555-1
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00723-014-0555-1